GMP Cell Therapy Consumables Market Report – Reach $59.98 Billion, Globally by 2028 with 27.5% CAGR During 2022-2028 | The Insight Partners
June 19, 2023 08:00 ET
|
The Insight Partners
Pune, India, June 19, 2023 (GLOBE NEWSWIRE) -- According to our latest study on "GMP Cell Therapy Consumables Market Size Report, Forecast to 2028 – COVID-19 Impact and Global Analysis – by Product,...
Global Immuno-Oncology Thematic Intelligence Report 2023: Focus on Trends in Bispecific Antibodies, Cancer Vaccines, Cell Therapies, Checkpoint Modulators, Cytokines, & Oncolytic Viruses
June 13, 2023 04:48 ET
|
Research and Markets
Dublin, June 13, 2023 (GLOBE NEWSWIRE) -- The "Immuno-Oncology - Thematic Intelligence" report has been added to ResearchAndMarkets.com's offering.This report includes coverage of immuno-oncology...
TILT Biotherapeutics Announces First Patient Dosed in Phase I Solid Tumors Trial Assessing Oncolytic Adenovirus TILT-123 in Combination with Checkpoint Inhibitor
May 15, 2023 02:00 ET
|
TILT Biotherapeutics Oy
HELSINKI, Finland, May 15, 2023 (GLOBE NEWSWIRE) -- TILT Biotherapeutics, a clinical-stage biotechnology company developing cancer immunotherapies, today announced that the first patient has been...
Global Natural Killer (NK) Cell Therapeutics Market Research Report 2023: 10 Recent Partnerships & Funding Deals, Clinical Trials Insight for 200 Therapies, Proprietary Technologies by Company
March 31, 2023 04:08 ET
|
Research and Markets
Dublin, March 31, 2023 (GLOBE NEWSWIRE) -- The "Global Natural Killer (NK) Cell Therapeutics Market Trends, Companies & Clinical Trials Insight 2023" report has been added to ...
Global GMP Protein (E. coli) Contract Manufacturing Market to Surpass US$ 1,439.1 Million by 2030, Says Coherent Market Insights (CMI)
January 05, 2023 09:30 ET
|
CMI
Burlingame, Jan. 05, 2023 (GLOBE NEWSWIRE) -- According to Coherent Market Insights, the global GMP protein (E. coli) contract manufacturing market is estimated to be valued at US$ 685.8 million in...
Immuno-oncology Global Market Report 2022: Approval of Novel Therapies Boosts Sector Growth
November 30, 2022 05:48 ET
|
Research and Markets
Dublin, Nov. 30, 2022 (GLOBE NEWSWIRE) -- The "Immuno-oncology Market Size, Share, Trends, Analysis and Forecast by Region, Segment, Type (Checkpoint Modulators, Cancer Vaccines) and End-User...
Provectus Biopharmaceuticals Expands Research Collaboration with The Rockefeller University to Investigate Clinical-Stage Immuno-Dermatology Agent PH-10 for Skin Inflammation
October 25, 2022 06:00 ET
|
Provectus Biopharmaceuticals Inc.
KNOXVILLE, TN, Oct. 25, 2022 (GLOBE NEWSWIRE) -- Provectus (OTCQB: PVCT) today announced that the Company has expanded its sponsored research program with James G. Krueger, MD, PhD, Co-director,...
Insights on the Cell Culture Global Market to 2028 - Featuring Corning, Lonza and VWR International Among Others
April 22, 2022 05:53 ET
|
Research and Markets
Dublin, April 22, 2022 (GLOBE NEWSWIRE) -- The "Cell Culture Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2021-2028" report has been added to...
Global Biologics Industry Forecast, 2026: Opportunities, Trends, Regulations, and Profiles of Major Competitors such as AbbVie, Amgen, and Roche
October 14, 2021 04:58 ET
|
Research and Markets
Dublin, Oct. 14, 2021 (GLOBE NEWSWIRE) -- The "Global Biologics Market Research Report: Forecast (2021-2026)" report has been added to ResearchAndMarkets.com's offering. The Global Biologics Market...
Masked Antibodies & Cytokines Landscape 2021 - Profiles of Key Stakeholders in Masking Technologies
October 08, 2021 08:43 ET
|
Research and Markets
Dublin, Oct. 08, 2021 (GLOBE NEWSWIRE) -- The "Masked Antibodies & Cytokines as Prodrugs: A Landscape Analysis of Stakeholders, Technologies, Pipelines, Business and Financing from An Industry...